Preclinical News and Research

RSS
COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

In vitro testing suggests effective novel drug combinations for SARS-CoV-2

Actively speaking two languages delays the onset of mild cognitive impairment

Actively speaking two languages delays the onset of mild cognitive impairment

IU School of Medicine wins $12.3 million grant for research into opioid addiction treatment

IU School of Medicine wins $12.3 million grant for research into opioid addiction treatment

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

Optimal antibody combinations and Fc binding inhibit SARS-CoV-2 in vivo

ERS Genomics and Applied StemCell sign agreement on commercialization of CRISPR gene editing tools

ERS Genomics and Applied StemCell sign agreement on commercialization of CRISPR gene editing tools

Point-of-care biomarker assay predicts traumatic brain injury in minutes

Point-of-care biomarker assay predicts traumatic brain injury in minutes

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Pfizer's anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2

Pfizer's anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

New strategies may be needed to reduce risk of falls in Alzheimer’s patients

New strategies may be needed to reduce risk of falls in Alzheimer’s patients

Researchers identify specific potential therapeutic targets for aggressive form of pancreatic cancer

Researchers identify specific potential therapeutic targets for aggressive form of pancreatic cancer

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy

RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19

RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19

NIH awards $26.56 million grant to create new Framingham Heart Study Brain Aging Program

NIH awards $26.56 million grant to create new Framingham Heart Study Brain Aging Program

New bone-on-a-chip device could revolutionize pharmaceutical pre-clinical testing

New bone-on-a-chip device could revolutionize pharmaceutical pre-clinical testing

India's whole-virion inactivated SARS-CoV-2 vaccine shows promise

India's whole-virion inactivated SARS-CoV-2 vaccine shows promise

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

New antitumor vaccines control melanoma growth in preclinical models

New antitumor vaccines control melanoma growth in preclinical models

Effective, simple, safe self-amplifying RNA vaccines

Effective, simple, safe self-amplifying RNA vaccines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.